CAS 1370651-20-9
:Formule :C26H27Cl2FN6O3
InChI :InChI=1S/C26H27Cl2FN6O3/c1-13-11-35(12-14(2)31-13)26(37)16-4-6-17(7-5-16)32-25(36)20-10-21(24(30)34-33-20)38-15(3)22-18(27)8-9-19(29)23(22)28/h4-10,13-15,31H,11-12H2,1-3H3,(H2,30,34)(H,32,36)/t13-,14+,15-/m1/s1
Code InChI :GLYMPHUVMRFTFV-QLFBSQMISA-N
SMILES :C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
8 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Ensartinib
CAS :Ensartinib (X-396) is a potent and orally active dual ALK/MET inhibitor for the treatment of ALK-positive non-small cell lung cancer (NSCLC).Formule :C26H27Cl2FN6O3Degré de pureté :99.92%Couleur et forme :SolidMasse moléculaire :561.446-Amino-5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-((3R,5S)-3,5-dimethylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide
CAS :6-Amino-5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-((3R,5S)-3,5-dimethylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamideFormule :C26H27Cl2FN6O3Degré de pureté :98%Masse moléculaire :561.44Ensartinib
CAS :Ensartinib is a small-molecule inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase. This product is derived from chemical synthesis and classified as a targeted cancer therapy. Ensartinib’s mode of action involves the selective inhibition of ALK phosphorylation, which blocks downstream signaling pathways involved in cell proliferation and survival.Formule :C26H27Cl2FN6O3Degré de pureté :Min. 95%Masse moléculaire :561.4 g/mol
